Results 41 to 50 of about 61,196 (252)

Cystatin C predicts cognitive decline in multiple system atrophy: A 1-year prospective cohort study

open access: yesFrontiers in Aging Neuroscience, 2022
BackgroundAccumulating evidence has suggested that cystatin C is associated with cognitive impairment in patients with neurodegenerative diseases. However, the association between cystatin C and cognitive decline in patients with multiple system atrophy (
Lingyu Zhang   +12 more
doaj   +1 more source

Differential in vitro and in vivo effect of barley cysteine and serine protease inhibitors on phytopathogenic microorganisms [PDF]

open access: yes, 2011
Protease inhibitors from plants have been involved in defence mechanisms against pests and pathogens. Phytocystatins and trypsin/α-amylase inhibitors are two of the best characterized protease inhibitor families in plants.
Cambra Marin, Ines   +5 more
core   +2 more sources

Certification of Cystatin C in the Human Serum Reference Material ERM-DA471/IFCC - Certified Reference Material ERM®-DA471/IFCC [PDF]

open access: yes, 2010
The production of ERM-DA471/IFCC, certified for the mass concentration of cystatin C, is described. Serum was produced from blood collected in 2 collection centres according to a procedure ensuring that it was obtained from healthy donors, and that the ...
ALTHAUS Harald   +8 more
core   +1 more source

Serum cystatin C measurement in differential diagnosis of intra and extrahepatic cholestatic diseases

open access: yesAnnals of Hepatology, 2010
Objective. Cystatin C is a very potent inhibitor of cysteine proteinases and, it has been clinically applied as a sensitive marker in monitoring of renal and liver functions.
Mehmet Buyukberber, Dr.   +7 more
doaj   +1 more source

Evaluation of cystatin C for the detection of chronic kidney disease in cats [PDF]

open access: yes, 2016
BackgroundSerum cystatin C (sCysC) and urinary cystatin C (uCysC) are potential biomarkers for early detection of chronic kidney disease (CKD) in cats. An in-depth clinical validation is required.
Abrahamson M   +9 more
core   +2 more sources

Beta-Trace Protein als endogener renaler Biomarker zur Bestimmung der Nierenfunktion bei Individuen im Alter von 70 Jahren und älter [PDF]

open access: yes, 2019
Background The exact measurement of glomerular filtration rate (GFR) is important for diagnostics and therapy of patients with chronic kidney disease. The common used filtration markers creatinine and cystatin C show some disadvantages.
Koep, Camilla
core   +1 more source

The Comparison of Creatinine and Cystatin C Value in Preeclampsia Severity and Neonatal Outcome [PDF]

open access: yes, 2016
Objectives: to compare the levels of creatinine and cystatin C with the severity of preeclampsia, and assess neonatal outcomes.Materials and Methods: Creatinine, cystatin C, and neonatal outcomes were assesed in 17 normotensive samples, 17 samples of ...
Wantania, J. (John)   +1 more
core  

Expression of a barley cystatin gene in maize enhances resistance against phytophagous mites by altering their cysteine-proteases [PDF]

open access: yes, 2011
Phytocystatins are inhibitors of cysteine-proteases from plants putatively involved in plant defence based on their capability of inhibit heterologous enzymes.
A Kiggundu   +49 more
core   +2 more sources

Cystatin C and Subclinical Brain Infarction [PDF]

open access: yesJournal of the American Society of Nephrology, 2005
Subclinical brain infarcts (SBI) are common in the elderly and are associated with covert neurologic and cognitive impairment. Although renal impairment is associated with accelerated cerebrovascular disease and an increased risk for clinically apparent brain infarct, few studies have examined the relationship between renal function and SBI, and these ...
Stephen L, Seliger   +11 more
openaire   +2 more sources

Small Extracellular Vesicles from Neural Cells: Physiological and Pathological Roles, and Potential in Neurodegenerative Therapy

open access: yesAdvanced Healthcare Materials, EarlyView.
Neural cell–derived small extracellular vesicles (sEVs) are emerging as pivotal mediators in neurodegenerative diseases, exerting both pathogenic and therapeutic functions. This review synthesizes current evidence on how sEVs from distinct neural cell types regulate neurodegeneration, neuroprotection, biomarker discovery, and targeted drug delivery ...
Muhammad Waqas Salim   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy